Teva Fourth-Quarter Profit Rises

home   >   blogdigger

NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, reported higher fourth-quarter profit on Tuesday, helped by the weak U.S. dollar and European sales of gabapentin, its version of Pfizer Inc.'s epilepsy drug Neurontin.

- link to Teva Fourth-Quarter Profit Rises -
Last update: 05/26/2005

Recommended Reading

    Atypical Antipsychotics for Treating Depression.(Zyprexa, Risperdal, Seroquel, and Zeldox) : An article from: Behavioral Health Management
    El gesticulador: Pieza para demagogos en tres actos
    Latest drug scourge blamed for deaths in park; Evidence indicates the men at Oscar Scherer overdosed on OxyContin.(A SECTION) : An article from: Sarasota Herald Tribune
    Epogen: A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References
    COX-2 Inhibitors Are 'Safer Aspirins,' Not 'Superaspirins'.(Brief Article) : An article from: Family Practice News
    Poltica y toros: verdad y apariencia.(ilegalizacin del partido Herri Batasuna como parte de plan para prevenir actos terroristas; Espaa)(TT: Bullfight ... pain)(Artculo Breve) : An article from: Epoca
    The Sirian Experiments: The Report by the Ambien II, of the Five
    2 students face drug charges; The L.A. Ainger middle-schoolers are suspended over the alleged sale of OxyContin at school.(B SECTION) : An article from: Sarasota Herald Tribune